NTBLQ — Notable Labs Income Statement
0.000.00%
Last trade - 00:00- $0.00m
- -$3.79m
- $0.31m
Annual income statement for Notable Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.562 | 0.922 | 0.768 | 0.658 | 0.31 |
| Cost of Revenue | |||||
| Gross Profit | 0.34 | 0.528 | 0.403 | 0.554 | 0.113 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 20.6 | 25.4 | 30.8 | 33.5 | 15 |
| Operating Profit | -20.1 | -24.5 | -30 | -32.9 | -14.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -19.4 | -24.2 | -29.9 | -32.3 | -11.3 |
| Net Income After Taxes | -19.4 | -24.2 | -29.9 | -32.3 | -11.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -19.4 | -24.2 | -29.9 | -32.3 | -11.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -19.4 | -24.2 | -29.9 | -32.3 | -11.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -18.7 | -19.2 | -15.6 | -14.6 | -3.41 |